Lower Back Pain Articles & Analysis
45 news found
However, inadequate ergonomics can result in chronic pain, musculoskeletal disorders (MSDs), fatigue, and shortened careers, with studies indicating that up to 80% of these professionals suffer from work-related pain, such as lower back discomfort, neck stiffness, or carpal tunnel syndrome.1-2 By adopting ergonomic practices, ...
(Tris), a commercial-stage biopharmaceutical company focused on ADHD, pain and neurological disorders, today announced new data from a human abuse potential (HAP) study of cebranopadol (TRN-228) which suggest the investigational compound has significantly lower abuse potential compared to both schedule II and schedule IV opioids. ...
Multiple clinical studies have demonstrated that cebranopadol is efficacious in different types of pain. Additionally, studies have shown that cebranopadol has significantly lower risks of abuse, withdrawal, physical dependence and overdose. ...
("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced positive two-year follow-up data for the Company's StemSpine® pilot study, showing significant efficacy of the StemSpine® procedure for treating chronic ...
Not to be confused with epidural anesthesia that’s used to sedate the expecting mother during childbirth, epidural injections provide pain relief from back or leg pain. Epidural injections are especially effective at treating lower back pain and radicular pain, but they ...
("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, neurology, and orthopedics, today announced the peer reviewed publication of positive, two-year follow-up data for the Company's StemSpine® study, showing significant efficacy of the StemSpine® procedure for treating ...
Significant Drop in Mobility Due to Chronic Low Back Pain (CLBP) Demonstrated in New Mobility Index, with Highest Drop Among Those in Their 50s Treatment is Deficient with 15% Currently Taking Opioids Despite CDC Guidelines Noting Inadequate Effectiveness and Inherent Risks Only 5% Utilizing Recommended Minimally Invasive Treatment Options The Harris Poll, a Stagwell (NASDAQ: STGW) ...
Excite Medical recently displayed their groundbreaking spinal decompression machine at the Orlando Parker Seminar in Kissimmee, FL. Among dozens of products, the DRX9000 spinal decompression machine impressed healthcare and chiropractic professionals with its ability to alleviate chronic back and neck pain while simultaneously improving the wellbeing of patients. Excite was one of many vendors ...
Relievant Medsystems shared today that the company’s breakthrough chronic low back pain treatment, the Intracept Procedure, was featured on NBC’s TODAY this morning. The full segment can be viewed here. “This is an exciting story, not only for the patients I’ve treated, but also for the millions of patients with chronic vertebrogenic low back pain who will now learn about ...
Excite Medical, the leading provider of non-surgical spinal decompression machines for back pain and neck pain, recently showcased its innovative and groundbreaking DRX9000® spinal decompression machine at the Florida Chiropractic Association’s (FCA) Northeast Regional Convention and Expo, held at the World Golf Renaissance in St. Augustine, FL. Excite was one of dozens of vendors and ...
Excite Medical is proud to announce Lieutenant Colonel Todd Geohagan (ret.) as its first VP of Veteran and Military Affairs. LTC Geohagan served nearly 30 years in the United States Air Force. His experience and connection to the military community will be instrumental in expanding access to Excite’s innovative technology, while supporting those who have served, and are currently serving ...
Excite Medical, the maker of the revolutionary DRX9000™ spinal decompression machine, participated in a successful trade mission to Quito, Ecuador April 4–7, facilitated by Enterprise Florida. “It was an honor to participate in this trade mission to Ecuador, meet leaders and executives, and help spread the word about non-surgical, drug-free treatments for low back pain,” ...
Transformative closed-loop technology senses the spinal cord’s response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment Long-term results published in two premier clinical journals show clinically meaningful improvements in pain relief, physical and emotional functioning, sleep quality, and health-related quality of life Saluda Medical Pty ...
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection; improvements were sustained at the one-year interim readout with additional data to follow at 18 and 24 months. Salt Lake City, UT – February 25, 2022 – ...
Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today that new Category I Current Procedural Terminology (CPT) codes for the Intracept Procedure are in effect as of January 1, 2022. The new Category I codes for the Intracept Procedure are: 64628: Thermal destruction of intraosseous basivertebral nerve, ...
DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc today announced the appointment of two new independent members to the company’s board of directors, Jeffrey Dunn and Eric Major. These appointments bring Mainstay’s total board membership to seven. “We are pleased to welcome these two transformational business leaders as new independent directors on the ...
There is a high unmet medical need in chronic pain, particularly among patients with concomitant opioid use problems. ...
Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 24-month results from a Level 1, prospective, randomized, multi-center trial (INTRACEPT) that further validate the safety, effectiveness, and durability of the Intracept® Procedure for patients with vertebrogenic CLBP. The study reported outcomes for ...
Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code specifically for vertebrogenic low back pain. The new diagnosis code – M54.51 ...
Locate’s portfolio now includes CertOss, a family of synthetic graft substitutes; CognitOss, a controlled and responsive release of antibiotics from a resorbable bone graft for the treatment of osteomyelitis; LDGraft a low dose, controlled-release rhBMP-2 spinal fusion product intended for the treatment of lower back pain caused by ...